Literature DB >> 25579246

Usefulness of antibodies and minor salivary gland biopsy in the study of sicca syndrome in daily clinical practice.

Maria Lida Santiago1, Maria Renata Seisdedos2, Rodrigo Nicolás Garcia Salinas2, Antonio Catalán Pellet2, Liliana Villalón3, Anastasia Secco2.   

Abstract

OBJECTIVES: To assess the association between histologic findings in the minor salivary gland biopsy (MSGB) and anti La (La/SS-B)y antiRo antibodies (Ro/SS-A), antinuclear antibodies (ANA) and Rheumatoid Factor (RF),and compare the value of the latter as diagnostic tests with MSGB, considered as the gold standard. MATERIAL AND
METHOD: Patients with suspected Primary Sjögren Syndrome (PSS) referred for MSGB were included. Antibody measurements were performed. Grade III and IV biopsy results were considered positive.
RESULTS: Two hundred and eighteen (218) patients were included, 95% females, with a median age of 54 years and 12 months median duration of sicca symptoms. 36 of the biopsies were positive. 33% of patients had positive anti Ro/SS-A anti La/SS-B antibodies, 62% had positive ANA, and 31% positive RF. A statistically significant association was found between MSGB and anti Ro/SS-A anti La/SS-B, ANA and RF. ANA were the most sensitive antibodies (84%. 95% CI: 75- 92), and the most specific were: Anti Ro/ SS-A and/or anti La/ SS-B (78%. 95% CI: 71-85) and RF (78%. 95% CI: 69-87).
CONCLUSION: On PSS clinical suspicion, anti Ro/ SS-A y anti La/ SS-B antibodies have a great value to achieve the diagnosis, with MSGB useful for diagnosis of seronegative patients. The results also suggest the importance of ANA and RF for PSS classification.
Copyright © 2015 Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Anti La/SS-B; Anti Ro/SS-A; Biopsia de glándula salival; Complejo sicca; Salivary gland biopsy; Sicca complex; Sjögren

Mesh:

Substances:

Year:  2015        PMID: 25579246     DOI: 10.1016/j.reuma.2014.06.004

Source DB:  PubMed          Journal:  Reumatol Clin        ISSN: 1699-258X


  4 in total

Review 1.  Diagnostic performance of serology against histologic assessment to diagnose Sjogren's syndrome: a systematic review.

Authors:  Luiz Claudio Viegas-Costa; Reid Friesen; Carlos Flores-Mir; Timothy McGaw
Journal:  Clin Rheumatol       Date:  2021-06-17       Impact factor: 2.980

2.  Risk of Parkinson disease in Sjögren syndrome administered ineffective immunosuppressant therapies: A nationwide population-based study.

Authors:  Uei-Han Ju; Feng-Cheng Liu; Chin-Sheng Lin; Wen-Yen Huang; Te-Yu Lin; Chih-Hao Shen; Yu-Ching Chou; Cheng-Li Lin; Kuen-Tze Lin; Chia-Hung Kao; Chao-Hsien Chen; Tse-Yen Yang
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

3.  Clinical and laboratory features of patients with focal lymphocytic sialadenitis on minor salivary gland biopsy for sicca symptoms: A single-center experience.

Authors:  Bibi Ayesha; Ruth Fernandez-Ruiz; Devin Shrock; Brittney M Snyder; Scott M Lieberman; Rebecca Tuetken; Elizabeth Field; Namrata Singh
Journal:  Medicine (Baltimore)       Date:  2021-04-02       Impact factor: 1.817

4.  Sjögren's syndrome.

Authors:  Fiona André; Barbara C Böckle
Journal:  J Dtsch Dermatol Ges       Date:  2022-07-01       Impact factor: 5.231

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.